STOCK ALARM
PRO
SA
PRO
News
Screener
Alerts
Research
More
⌘K
⌘J
Pro
Sign In
Free Account
Themes
Dermata Therapeutics, Inc.
DRMA
NASDAQ
Loading
Overview
Intelligence
Charts
News
Fundamentals
Key Metrics
Financials
Growth
Insiders
Analysis
More
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Loading chart...
As of
2024
• vs 2023
Annual
Quarterly
Core Metrics
Market Cap
$206.55K
+16.4%
P/E Ratio
-0.02
+26.2%
P/S Ratio
0.00
ROE
-787.11%
-541.7%
ROIC
-801.57%
-533.4%
FCF Yield
-5404.48%
-49.7%
Debt/Equity
0.00
Current Ratio
1.79
-63.5%
Interest Coverage
0.00x
Per Share
Revenue/Share
$0.00
Net Income/Share
$-80.31
+80.0%
Operating CF/Share
$-72.96
+77.9%
Free CF/Share
$-72.96
+77.9%
Cash/Share
$20.66
-94.6%
Book Value/Share
$10.20
-96.9%
Tangible Book/Share
$10.20
-96.9%
Equity/Share
$10.20
-96.9%
Interest Debt/Share
$0.00
Valuation
Market Cap
$206.55K
+16.4%
Enterprise Value
-$2.96M
+59.3%
P/E Ratio
-0.02
+26.2%
P/S Ratio
0.00
P/OCF Ratio
-0.02
+33.2%
P/FCF Ratio
-0.02
+33.2%
P/B Ratio
0.13
+373.7%
P/TB Ratio
0.13
+373.7%
EV/Sales
0.00
EV/EBITDA
0.24
+100.8%
Profitability
Earnings Yield
-5948.90%
-35.5%
FCF Yield
-5404.48%
-49.7%
ROE
-787.11%
-541.7%
ROIC
-801.57%
-533.4%
Return on Tangible Assets
-347.70%
-255.9%
Capital Allocation
CapEx/OCF
0.00%
CapEx/Revenue
0.00%
CapEx/Depreciation
0.00
SBC/Revenue
0.00%
Balance Sheet
Debt/Equity
0.00
Debt/Assets
0.00
Net Debt/EBITDA
0.26
+100.9%
Current Ratio
1.79
-63.5%
Interest Coverage
0.00x
Income Quality
0.91
+10.5%
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$7.77
-97.4%